Instrument-free, rapid genetic testing platform for agriculture and environmental monitoring. Uses Recombinase Polymerase Amplization combined with Lateral Flow Tests and direct plant crude sap to detect single-copy plant genetic inserts, SNPs, and GMOs in under 30 minutes—delivering lab-quality results in the field without specialized equipment or expertise.
This solution offers a rapid, instrument-free genetic testing platform designed for real-world agricultural and environmental settings. By combining Recombinase Polymerase Amplification (RPA) with Lateral Flow Test (LFT) technology and using direct plant crude sap as a template, the platform enables on-site detection of plant genetic inserts, Single Nucleotide Polymorphisms (SNPs), and Genetically Modified Organisms (GMOs) at single-copy sensitivity. Results are available in approximately 25–30 minutes from sample collection, eliminating the need for laboratory infrastructure, nucleic acid purification, or trained technicians. The approach addresses a critical gap in field-based decision-making for crop management, disease outbreak response, food safety assurance, and environmental risk assessment, where traditional lab-based testing is too slow and impractical.
The underlying RPA-LFT methodology has been validated over more than a decade through the development of over fourteen on-site plant virus detection kits. The current research program aims to extend this proven platform to plant genetic inserts, SNPs, and GMOs through a phased plan: literature review, methodology development (3 months), assay validation including specificity, sensitivity, and environmental testing (4 months), field testing across diverse crops (3 months), and cost-effectiveness analysis (1.5 months). The approach is positioned for scalability and broad adoption by non-expert users in agricultural and environmental monitoring contexts.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.